Visit Us at Antibody Engineering & Therapeutics 2026 in Booth #213
Join us at Antibody Engineering & Therapeutics 2026 in Booth #213
Biologics development doesn’t happen in one tool. A molecule moves from sequence to design to physical material to registered, characterized data, often across different teams, software, and vendors.
At AE&T, see how Geneious, BioGlyph, and Luma work as one connected path from sequence to registered molecule, so your R&D teams can fast-track antibodies from discovery to the clinic without losing structure or context along the way.
Visit us at Booth #213 to see the full workflow in action.

